HONORHEALTH JOHN C. LINCOLN MED CTR
1. Target Overview & Investment Thesis
HONORHEALTH JOHN C. LINCOLN MED CTR is a 258-bed safety-net/medicaid heavy in MARICOPA, AZ with $618.4M in net patient revenue and a -7.9% operating margin. The hospital serves a payer mix of 22.4% Medicare, 30.2% Medicaid, and 47.4% commercial.
Thesis: Undervalued. Our ML models identify $45.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -7.9% to -0.5% (+736bps).
| Net Revenue HCRIS | $618.4M |
| Current EBITDA COMPUTED | $-48.8M |
| Operating Margin COMPUTED | -7.9% |
| Occupancy HCRIS | 73.6% |
| Revenue / Bed COMPUTED | $2.4M |
| Net-to-Gross HCRIS | 16.9% |
| Distress Probability ML | 46.3% |
2. Market Context & Competitive Position
AZ has 124 Medicare-certified hospitals with a median operating margin of -0.8%. The target's margin of -7.9% places it below the state median. Among 37 size-comparable peers (129-516 beds), the median margin is -1.0%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (129-516), prioritizing same-state peers. 37 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| HONORHEALTH JOHN C. LINCOLN ME (Target) | AZ | 258 | $618.4M | -7.9% |
| MAYO CLINIC HOSPITAL | AZ | 315 | $2.25B | 1.4% |
| BANNER ESTRELLA MEDICAL CENTER | AZ | 317 | $1.84B | 79.2% |
| BANNER BAYWOOD MEDICAL CENTER | AZ | 323 | $1.39B | 79.1% |
| ST. JOSEPHS HOSPITAL & MEDICAL | AZ | 515 | $1.31B | -17.7% |
| PHOENIX CHILDRENS HOSPITAL | AZ | 352 | $1.26B | 6.0% |
| TUCSON MEDICAL CENTER | AZ | 499 | $747.4M | -2.8% |
| CHANDLER REGIONAL MEDICAL CENT | AZ | 429 | $700.3M | -2.0% |
| YUMA REGIONAL MEDICAL CENTER | AZ | 406 | $670.8M | 6.3% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $45.5M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $13.0M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $12.4M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $12.2M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $7.5M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $396K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-48.8M |
| + RCM Uplift | +$45.5M |
| Pro Forma EBITDA | $-3.3M |
| Current Margin | -7.9% |
| Pro Forma Margin | -0.5% |
| WC Released (1x) | $23.7M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-75.1M | $133.2M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-75.1M | $122.1M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-67.6M | $247.9M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-67.6M | $250.5M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-82.6M | $-70.0M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-82.6M | $-103.9M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Elevated Medicaid exposure (30.2%) | Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims |
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 37 hospitals with 129-516 beds
- Same-state prioritization (n=38)
- Comp margins: P25=-6.2% / P50=-1.0% / P75=6.3%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.